Department of Endocrinology, Diabetes and Metabolism, NYU Langone Medical Center, New York, New York, USA.
Department of Radiology, NYU Langone Medical Center, New York, New York, USA.
World Neurosurg. 2022 May;161:e274-e281. doi: 10.1016/j.wneu.2022.01.119. Epub 2022 Feb 4.
Silent corticotroph adenomas (SCAs) behave more aggressively than other non-functioning adenomas (NFAs). This study aims to expand the body of knowledge of the behavior of SCAs.
Retrospective analysis of 196 non-corticotroph NFAs and 20 SCAs from 2012-2017 was completed. Demographics, clinical presentation, imaging, and biochemical data were gathered. The primary endpoint was to identify features of SCAs versus other NFAs that suggest aggressive disease, including pre-surgical comorbidities, postoperative complications, extent of tumor, and recurrence. Golden-angle radial sparse parallel (GRASP) magnetic resonance images were obtained from a subset of SCAs and NFAs. Permeability data were obtained to compare signal-to-time curve variation between the 2 groups.
With multivariate regression analysis, SCAs showed higher rates of hemorrhage on preoperative imaging than NFAs (P = 0.017). SCAs presented more frequently with headache (P = 0.012), vision changes (P = 0.041), and fatigue (P = 0.028). SCAs exhibited greater extent of tumor burden with increased occurrence of stalk deviation (P = 0.008), suprasellar invasion (P = 0.021), optic chiasm compression (P = 0.022), and cavernous sinus invasion (P = 0.015). On GRASP imaging, SCAs had significantly lower permeability of contrast than NFAs (P = 0.001). Thirty percent of SCAs were noted to recur with a 14% recurrence rate in other NFAs, though this difference was not of statistical significance (P = 0.220).
SCAs exhibit features of more aggressive disease. Interestingly, a significant increase in recurrence was not seen despite these features. The results of this study support the growing body of evidence that SCAs behave more aggressively than other NFPAs and was able to provide some insight into factors that may contribute to recurrence.
静默型促肾上腺皮质激素腺瘤(SCA)比其他无功能腺瘤(NFA)表现更具侵袭性。本研究旨在扩大对 SCA 行为的认识。
对 2012 年至 2017 年间的 196 例非促肾上腺皮质激素 NFAs 和 20 例 SCA 进行回顾性分析。收集了人口统计学、临床表现、影像学和生化数据。主要终点是确定 SCA 与其他 NFAs 相比具有侵袭性疾病的特征,包括术前合并症、术后并发症、肿瘤程度和复发。从一组 SCA 和 NFAs 中获得了黄金角径向稀疏并行(GRASP)磁共振成像。获得了渗透性数据以比较两组之间的信号-时间曲线变化。
通过多变量回归分析,SCA 术前影像学上出血率高于 NFA(P=0.017)。SCA 更常表现为头痛(P=0.012)、视力改变(P=0.041)和疲劳(P=0.028)。SCA 表现出更大的肿瘤负担程度,出现茎突偏斜(P=0.008)、鞍上侵犯(P=0.021)、视交叉受压(P=0.022)和海绵窦侵犯(P=0.015)的发生率更高。在 GRASP 成像上,SCA 的对比渗透性明显低于 NFA(P=0.001)。30%的 SCA 复发,而其他 NFA 的复发率为 14%,但差异无统计学意义(P=0.220)。
SCA 表现出侵袭性更强的疾病特征。有趣的是,尽管存在这些特征,但并未观察到复发率显著增加。本研究结果支持越来越多的证据表明 SCA 比其他 NFPA 表现更具侵袭性,并为可能导致复发的因素提供了一些见解。